In lawsuit challenging FDA approval of abortion pills, state attorneys general weigh in

Norge Nyheter Nyheter

In lawsuit challenging FDA approval of abortion pills, state attorneys general weigh in
Norge Siste Nytt,Norge Overskrifter
  • 📰 NBCNewsHealth
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 51%

A decision from a Trump-appointed judge could come later this month in a lawsuit alleging that the FDA’s approval of two abortion medications was unlawful.

In court filings last month, the FDA said its approval of mifepristone came after extensive review of the scientific evidence. The agency called the lawsuit “extraordinary and unprecedented,” adding that the plaintiffs have asked the court to upend “longstanding scientific determination based on speculative allegations of harm offered in support of claims and arguments that are untimely, unexhausted, and without merit.

“Blocking access to this safe and effective medication is a dangerous attack on reproductive freedom and public health,” James said in a statement. “Decades of medical and clinical research have proven that medication abortion is safe. Despite these facts and its widespread use, we know this is not a debate about science.”

Vi har oppsummert denne nyheten slik at du kan lese den raskt. Er du interessert i nyhetene kan du lese hele teksten her. Les mer:

NBCNewsHealth /  🏆 707. in US

Norge Siste Nytt, Norge Overskrifter

Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.

Trump Aide-Turned-Critic Warns That DeSantis Will ‘Implode’ Against TrumpTrump Aide-Turned-Critic Warns That DeSantis Will ‘Implode’ Against TrumpThe View’s Alyssa Farah Griffin asserted on Thursday that Ron DeSantis would quickly fold under the pressure of a heated GOP primary against Donald Trump, adding that the Florida governor will “implode” in the face of sustained attacks.
Les mer »

FDA Approves Abrocitinib for Adolescents With Atopic DermatitisFDA Approves Abrocitinib for Adolescents With Atopic DermatitisFDA expanded the indication for Pfizer's oral JAK inhibitor for atopicdermatitis, abrocitinib, to include adolescents aged 12 through 17 years. DermTwitter
Les mer »

Embattled iPLEDGE Program: Changes Ahead?Embattled iPLEDGE Program: Changes Ahead?The FDA announced that two FDA advisory committees will meet in March to discuss proposed changes to the embattled program to ''minimize burden on patients, pharmacies, and prescribers.'
Les mer »

Poll: Donald Trump Double Digits Ahead of Potential GOP ChallengersPoll: Donald Trump Double Digits Ahead of Potential GOP ChallengersFormer President Donald Trump is ahead of his potential 2024 Republican challengers by double digits, a Tuesday Morning Consult survey found.
Les mer »

Former fixer Michael Cohen meets with prosecutors investigating Donald TrumpFormer fixer Michael Cohen meets with prosecutors investigating Donald TrumpDonald Trump's one-time lawyer and fixer Michael Cohen met with prosecutors investigating the former president's role in alleged hush payments to Stormy Daniels before the 2016 election.
Les mer »



Render Time: 2025-03-06 14:56:32